Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?]

L'Encephale - 1 Jun 2020

Frajerman A, Kebir O, Chaumette B, Tessier C, Lamazière A, Nuss P, Krebs M-O

Abstract excerpt

The various roles of membrane lipids in human health has urged researchers to study their impact in neuropsychiatric diseases, especially in schizophrenia spectrum disorders and more recently in early stages of psychosis. The progress in mass spectrometry technologies now allows a more comprehensive analysis of phospholipids (PL) and their fatty acid (FA) molecular species. FA are defined by a carbon chain of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cognitive Dysfunction
Share to Dietary Supplements

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fatty Acids, Omega-3

Share to Lipidomics

Share to Membrane Lipids

Share to Molecular Targeted Therapy

Share to Prodromal Symptoms

Share to Psychotic Disorders

Source

Identifiers

PMID: 32151446
DOI: 10.1016/j.encep.2019.11.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Membrane lipids in schizophrenia and early phases of psychosis: Potential biomarkers and therapeutic targets?]PMID 32151446Read ↗

From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismSemantic proximity Read ↗

Platelets: A possible glance into brain biological processes in schizophreniaSemantic proximity Read ↗

Ceramide signalling in inherited and multifactorial brain metabolic diseasesSemantic proximity Read ↗

Relevance of Diet in Schizophrenia: Focusing on Prenatal Nutritional Deficiency, Obesity, Oxidative Stress and InflammationSemantic proximity Read ↗

Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanismsSemantic proximity Read ↗

Association between lipid metabolism and cognitive function in patients with schizophreniaSemantic proximity Read ↗

Red cell membrane fatty acids, cytosolic phospholipase-A2 and schizophrenia.Semantic proximity Read ↗

Dysregulated lipid metabolism precedes onset of psychosis in people at clinical high riskSemantic proximity Read ↗

Focus on fatty acids in the neurometabolic pathophysiology of psychiatric disordersSemantic proximity Read ↗

Schizophrenia: from mechanism to therapy.Semantic proximity Read ↗

Lipid-correlated alterations in the transcriptome are enriched in several specific pathways in the postmortem prefrontal cortex of Japanese patients with schizophreniaSemantic proximity Read ↗

An Update on Promising Biomarkers in SchizophreniaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.